AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
Holders of 5% or more of AEON
Holders whose latest Schedule 13D or 13G filing reports 5% or more of AEON Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Daewoong Co., Ltd | 13D | 49.99%12.0M shares | +49.09 ppfrom 0.90% | Jan 29, 20262 filings | Jan 29, 2026 | SEC |
| Chernett Jorey | 13G | 9.90%1.13M shares | New | May 30, 20251 filing | May 30, 2025 | SEC |
| Dauntless Investment Group, LLC | 13G | 9.70%108.2K shares | New | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Bigger Capital Fund L P | 13G | 6.10%4.90M shares | New | Jan 8, 20251 filing | Jan 8, 2025 | SEC |
| Palmisano Robert J | 13D/A | 5.70%2.27M shares | 0.00 ppfrom 5.70% | Jan 22, 20252 filings | Mar 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on AEON Biopharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 20269:24 PM ET | Daewoong Co., Ltdand 1 other | 13D | 49.99%12.0M shares | +49.09 ppfrom 0.90% | Jan 21, 2026 | SEC |
| Jan 29, 20269:03 PM ET | Daewoong Co., Ltdand 1 other | 13D/A | 0.90%91.4K shares | –Below 5% | Mar 24, 2025 | SEC |
| Oct 14, 20254:17 PM ET | Alta Partners LLC | 13G/A | 2.10%249.9K shares | −3.00 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Jul 9, 202512:33 PM ET | Alta Partners LLC | 13G/A | 5.10%586.3K shares | −1.13 ppfrom 6.23% | Jun 30, 2025 | SEC |
| May 30, 202512:10 PM ET | Chernett Jorey | 13G | 9.90%1.13M shares | New | May 27, 2025 | SEC |
| May 15, 20257:21 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 4.11%465.0K shares | −5.88 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20256:35 PM ET | S.H.N. Financial Investments Ltd. | 13G/A | 0.00%0 shares | −6.00 ppfrom 6.00%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20257:07 AM ET | Polar Asset Management Partners Inc. | 13G/A | 0.00%0 shares | −6.90 ppfrom 6.90%Below 5% | Mar 31, 2025 | SEC |
| Mar 10, 20258:45 AM ET | Alta Partners LLC | 13G | 6.23%629.6K shares | New | Feb 28, 2025 | SEC |
| Mar 7, 20254:01 PM ET | Palmisano Robert Jand 1 other | 13D/A | 5.70%2.27M shares | 0.00 ppfrom 5.70% | Jul 25, 2024 | SEC |
| Mar 3, 20251:51 PM ET | Dauntless Investment Group, LLC | 13G | 9.70%108.2K shares | New | Feb 26, 2025 | SEC |
| Feb 14, 20255:09 PM ET | Blue Owl Capital Holdings LP | 13G/A | 3.81%3.05M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:44 PM ET | Polar Asset Management Partners Inc. | 13G/A | 6.90%2.76M shares | – | Dec 31, 2024 | SEC |
| Jan 22, 20254:02 PM ET | Palmisano Robert Jand 1 other | 13D | 5.70%2.27M shares | New | Jul 25, 2024 | SEC |
| Jan 13, 20254:14 PM ET | S.H.N. Financial Investments Ltd. | 13G | 6.00%5.40M shares | New | Jan 6, 2025 | SEC |
| Jan 13, 20254:08 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 9.99%8.96M shares | New | Jan 6, 2025 | SEC |
| Jan 8, 20254:15 PM ET | Bigger Capital Fund L Pand 6 others | 13G | 6.10%4.90M shares | New | Jan 6, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell AEON Biopharma, Inc. shares.
No Form 144 notices for AEON Biopharma, Inc. are on file.